News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
e Groupe Freeland, soutenu majoritairement par MML, accompagné de IDI et BPI, finalise sa 7ème opération de croissance externe en 6 ans
Le Groupe Freeland annonce l'acquisition de Mindquest, plateforme de recrutement de talents en IT et finance, afin de renforcer sa position sur le marché et optimiser le processus de sélection des profils hautement qualifiés -
-
-
COMMUNIQUÉ DE PRESSE
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement
Applied DNA Sciences announces repositioning of TR8™ PGx testing service to offer tailored subpanels targeting genetic variants correlated with DPD enzyme deficiencies in cancer patients, following recent FDA safety announcement -
COMMUNIQUÉ DE PRESSE
Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Lisata Therapeutics Inc (ISIN: US1280583022) research with a Buy recommendation and USD 15.00 target price. Lisata's FY/24 results exceeded expectations, with promising developments in certepetide trials and AI collaboration -
-
-
-
COMMUNIQUÉ DE PRESSE
SYNBIOTIC presents medical cannabis as a pastille for the German market for the first time
SYNBIOTIC SE presents medical cannabis pastilles on the German market for the first time, offering a new, personalized, and effective dosage form. Partnering with BOLDER Arzneimittel, this innovation sets new standards for cannabis therapy
